Elanco Animal Health Fundamentals Overview

By Chris Stiles • Thursday, June 27 15:14 • Permanent Link

Elanco Animal Health sank -22.6% today, compared to the S&P 500's day change of 0.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:

Elanco Animal Health has moved 79.0% over the last year, and the S&P 500 logged a change of 24.6%
ELAN has an average analyst rating of buy and is -30.9% away from its mean target price of $20.13 per share
Its trailing earnings per share (EPS) is $-2.65
Elanco Animal Health has a trailing 12 month Price to Earnings (P/E) ratio of -5.2 while the S&P 500 average is 27.65
Its forward earnings per share (EPS) is $1.07 and its forward P/E ratio is 13.0
The company has a Price to Book (P/B) ratio of 1.13 in contrast to the S&P 500's average ratio of 4.59
Elanco Animal Health is part of the Health Care sector, which has an average P/E ratio of 27.53 and an average P/B of 3.61
ELAN has reported YOY quarterly earnings growth of -71.4% and gross profit margins of 0.6%
The company has a free cash flow of $84.75 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.